参考文献/References:
[1] AN Z,ZHAO R,HAN F,et al.Potential serum biomarkers associated with premature rupture of fetal membranes in the first trimester[J].Front Pharmacol,2022,13:915-935.
[2] 刘秋杨,朱慧芳,王迎春,等.黄芪四君子汤联合门冬胰岛素治疗妊娠期糖尿病临床研究[J].陕西中医,2021,42(10):1408-1411.
[3] 周立娜,张蕾,孙晓娜,等.妊娠期高血压疾病患者孕中期血小板参数、钙离子浓度、凝血指标与病情程度及母婴结局相关性研究[J].陕西医学杂志,2024,53(2):257-261.
[4] 胡琦芬.盐酸利托君联合硫酸镁治疗未足月早产胎膜早破的疗效及预后分析[J].湖南师范大学学报(医学版),2019,16(2):151-153.
[5] MURATA T,KYOZUKA H,YASUDA S,et al.Effects of acute tocolysis using ritodrine hydrochloride on foetal heart rate patterns in intrauterine foetal resuscitation:A retrospective,single-centre observational study[J].J Obstet Gynaecol,2022,42(4):563-568.
[6] SHIGEMI D,ASO S,YASUNAGA H.Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan:A retrospective cohort study using a national inpatient database[J].BMC Pregnancy Childbirth,2019,19(1):204.
[7] 李婧,杨红.间苯三酚联合盐酸利托君对前置胎盘患者胎盘血流指标及血清Eph A5、SF1t-1的影响[J].影像科学与光化学,2022,40(6):1545-1549.
[8] 林子.早产保胎使用单用硝苯地平与硝苯地平协同硫酸镁保胎效果评价[J].临床医药文献电子杂志,2020,7(83):157-170.
[9] BLUMENFELD Y J,LYELL D J.Prematurity prevention:The role of acute tocolysis[J].Curr Opin Obstet Gynecol,2009,21(2):136-141.
[10] 中华医学会.临床诊疗指南-妇产科学分册[M].北京:人民卫生出版社,2007:231-234.
[11] 高磊,刘晓巍,王建东.小孕龄未足月胎膜早破孕妇不良妊娠结局的影响因素分析[J].中国医药,2022,17(2):244-248.
[12] CHOI E K,KIM S Y,HEO J M,et al.Perinatal outcomes associated with latency in late preterm premature rupture of membranes[J].Int J Environ Res Public Health,2021,18(2):672.
[13] 王德亮,刘代兰,张爱凤.缩宫素与麦角新碱联合应用预防胎膜早破初产妇剖宫产产后出血的效果观察[J].中国临床药理学杂志,2023,39(18):2622-2625.
[14] 胡玉莹,朱锦明,刘洁,等.未足月胎膜早破孕妇血清中miR-223-3p的表达水平及临床意义[J].实用医学杂志,2024,40(9):1275-1279.
[15] LIU L,XU H J,CHEN J L,et al.Detection of vaginal metabolite changes in premature rupture of membrane patients in third trimester pregnancy:A prospective cohort study[J].Reprod Sci,2021,28(2):585-594.
[16] GIBSON K S,BRACKNEY K.Periviable premature rupture of membranes[J].Obstet Gynecol Clin North Am,2020,47(4):633-651.
[17] RONZONI S,BOUCOIRAN I,YUDIN M H,et al.Guideline No.430:Diagnosis and management of preterm prelabour rupture of membranes[J].J Obstet Gynaecol Can,2022,44(11):1193-1208.
[18] BOETTCHER L B,CLARK E A S.Neonatal and childhood outcomes following preterm premature rupture of membranes[J].Obstet Gynecol Clin North Am,2020,47(4):671-680.
[19] 杨金英,王倩菲.孕妇产前组织型绒毛膜羊膜炎与新生儿缺氧缺血性脑病相关性分析[J].陕西医学杂志,2023,52(2):188-191.
[20] ARMAN B M,BINDER N K,DE-ALWIS N,et al.Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth[J].Sci Rep,2023,13(1):5646.
[21] 曹卉,严芳,马梦雯.硝苯地平联合盐酸利托君对先兆早产母婴结局的影响[J].安徽医学,2020,41(7):778-781.
[22] 吉文倩,焦波,王艳,等.阿托西班联合硝苯地平对先兆早产胎膜早破患者的效果及对母婴结局的影响[J].西北药学杂志,2024,39(4):153-156.
[23] 蔡红霞,丁金玉,张明恩.四君子汤对妊娠期糖尿病患者血管内皮功能及妊娠结局的影响[J].陕西中医,2020,41(12):1708-1711.
[24] 刘婧,刘妮英,蒋依伶.硫酸镁联合盐酸利托君治疗未足月早产胎膜早破的临床价值分析[J].分子诊断与治疗杂志,2020,12(11):1514-1517.
[25] 盛丛,张鑫,黄慧.POF1B在自然流产孕妇绒毛膜中的表达及其相关作用机制研究[J].重庆医学,2024,53(7):1059-1063.
[26] 梁婵玉,朱燕莉.盐酸利托君对先兆早产患者血清Th1/Th2细胞因子及宫颈分泌物FFN、IGFBP-1、MMP表达水平的影响[J].广西医科大学学报,2017,34(3):386-389.
[27] 于立涛,曹克旦,严靖奕.硝苯地平联合硫酸镁在妊娠期高血压患者中的治疗效果[J].现代医学与健康研究:电子版,2023,7(1):77-80.